Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn’s disease or ulcerative colitis

Objective: To assess the effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in adults with moderate-to-severe active Crohn’s disease (CD) or ulcerative colitis (UC). Methods: This multi-centre, observational cohort study was conducted at medical centres in Romania, Cze...

Descripción completa

Detalles Bibliográficos
Autores principales: Gheorghe, Cristian, Svoboda, Pavel, Mateescu, Bogdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586088/
https://www.ncbi.nlm.nih.gov/pubmed/31259042
http://dx.doi.org/10.1080/21556660.2019.1626735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586088/
https://www.ncbi.nlm.nih.gov/pubmed/31259042
http://dx.doi.org/10.1080/21556660.2019.1626735

Ejemplares similares